Peluso John J, Griffin Daniel, Liu Xiufang, Horne Meghan
Department of Cell Biology, University of Connecticut Health Center, Farmington, Connecticut Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut
Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut.
Biol Reprod. 2014 Nov;91(5):104. doi: 10.1095/biolreprod.114.122986. Epub 2014 Sep 24.
Progesterone receptor membrane component 1 (PGRMC1) and PGRMC2 are expressed in rat granulosa cells and spontaneously immortalized granulosa cells (SIGCs) but their biological roles are not well defined. The present studies demonstrate that depleting either Pgrmc1 or Pgrmc2 in SIGCs increases entry into the cell cycle but does not increase cell proliferation. Rather, PGRMC1 and/or PGRMC2-deplete cells accumulate in metaphase and undergo apoptosis. Because both PGRMC1 and PGRMC2 localize to the mitotic spindle, their absence likely accounts for cells arresting in metaphase. Moreover, pull-down assays, colocalization studies and in situ proximity ligation assays (PLA) indicate that PGRMC1 binds PGRMC2. Disrupting the PGRMC1:PGRMC2 complex through the use of siRNA or the cytoplasmic delivery of a PGRMC2 antibody increases entry into the cell cycle. Conversely, overexpressing either PGRMC1-GFP or GFP-PGRMC2 fusion protein inhibits entry into the cell cycle. Subsequent studies reveal that depleting PGRMC1 and/or PGRMC2 reduces the percentage of cells in G0 and increases the percentage of cells in G1. These observations indicate that in addition to their role at metaphase, PGRMC1 and PGRMC2 are involved in regulating entry into the G1 stage of the cell cycle. Interestingly, both PGRMC1 and PGRMC2 bind GTPase-activating protein-binding protein 2 (G3BP2) as demonstrated by pull-down assays, colocalization assays, and PLAs. G3bp2 siRNA treatment also promotes entry into the G1 stage. This implies that dynamic changes in the interaction among PGRMC1, PGRMC2, and G3BP2 play an important protein regulating the rate at which SIGCs enter into the cell cycle.
孕激素受体膜组分1(PGRMC1)和PGRMC2在大鼠颗粒细胞和自发永生化颗粒细胞(SIGC)中表达,但其生物学作用尚未明确。目前的研究表明,在SIGC中敲除Pgrmc1或Pgrmc2会增加细胞进入细胞周期的比例,但不会增加细胞增殖。相反,PGRMC1和/或PGRMC2缺失的细胞会在中期积累并发生凋亡。由于PGRMC1和PGRMC2都定位于有丝分裂纺锤体,它们的缺失可能是细胞停滞在中期的原因。此外,下拉分析、共定位研究和原位邻近连接分析(PLA)表明PGRMC1与PGRMC2结合。通过使用小干扰RNA(siRNA)或细胞质递送PGRMC2抗体破坏PGRMC1:PGRMC2复合物会增加细胞进入细胞周期的比例。相反,过表达PGRMC1-GFP或GFP-PGRMC2融合蛋白会抑制细胞进入细胞周期。后续研究表明,敲除PGRMC1和/或PGRMC2会降低G0期细胞的百分比,并增加G1期细胞的百分比。这些观察结果表明,除了在中期的作用外,PGRMC1和PGRMC2还参与调节细胞进入细胞周期的G1期。有趣的是,下拉分析、共定位分析和PLA都表明PGRMC1和PGRMC2都与GTP酶激活蛋白结合蛋白2(G3BP2)结合。G3bp2 siRNA处理也会促进细胞进入G1期。这意味着PGRMC1、PGRMC2和G3BP2之间相互作用的动态变化在调节SIGC进入细胞周期的速率中起着重要作用。